Cancer Clinical Trials: What the Public Health and Primary Care Provider Need to Know


At the conclusion of the presentation, the participants will be able to:

  1. List basic principles relating to cancer clinical trials, including purpose/limitations of Phase I, II and III clinical trials.
  2. Describe the benefits associated with cancer clinical trials, using lessons learned and best practices gleaned from pediatric cancer clinical trials as a model.
  3. Recognize barriers to participation in clinical trials among adults at-risk for or affected with cancer and identify disparities in clinical trial participation.

* Fields marked with an asterisk are required

Participant Information

4. Are you Hispanic, Latino/a, or Spanish origin? * (One or more categories may be selected)
5. What is your race? * (One or more categories may be selected)

Program Evaluation

Using the rating scale, please rate the following.


Objectives/Learner's achievement of each objective
12. As a result of this educational activity, I am able to:


Presenter 1
13. Yelena Novik, MD, FACP, Assistant Professor; Medical Director-Clinical Trials Office, NYU Clinical Cancer Center, Department of Medicine (Residency Program), NYU Medical Oncology Associates

Presenter 2
14. Michael L. Pearl, MD, FACOG, FACS, Professor and Director, Division of Gynecological Oncology, Stony Brook University Hospital

Presenter 3
15. (Not applicable)

Presenter 4
16. (Not applicable)

Presenter 5
17. (Not applicable)

Conflict of Interest

Outcomes of Education

23. Please list up to three specific barriers you have identified that will prevent you from incorporating what you have learned into practice.


24. Please list up to three specific strengths of this learning activity/offering.

25. Please list up to three specific areas to improve this learning activity/offering.

Submit Evaluation

(Not eligible for continuing education credits)